Hillevax
Amy E. is currently the Director of Human Resources at HilleVax, with previous experience in similar roles at Alaunos Therapeutics, Ziopharm Oncology, Dogwood Pharmaceuticals, Clinical Data Inc., and Genaissance Pharmaceuticals. Amy holds a Master's degree in Industrial/Organizational Psychology from the University of New Haven and a Bachelor's degree in Psychology from Saint Anselm College.
This person is not in any offices
Hillevax
2 followers
HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines. Their initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection.